Latest BVF INC/IL Stock Portfolio

BVF INC/IL Performance:

2024 Q4: -6.81%YTD: -0.19%2023: 6.53%

Performance for 2024 Q4 is -6.81%, and YTD is -0.19%, and 2023 is 6.53%.

About BVF INC/IL and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, BVF INC/IL reported an equity portfolio of $3 Billions as of 31 Dec, 2024.

The top stock holdings of BVF INC/IL are MLTX, KYMR, RVMD. The fund has invested 36.2% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 7% of portfolio in KYMERA THERAPEUTICS INC.

The fund managers got completely rid off IONIS PHARMACEUTICALS INC (IONS), IDEAYA BIOSCIENCES INC (IDYA) and CG ONCOLOGY INC stocks. They significantly reduced their stock positions in 4D MOLECULAR THERAPEUTICS IN (FDMT), THIRD HARMONIC BIO INC (THRD) and OLEMA PHARMACEUTICALS INC (OLMA). BVF INC/IL opened new stock positions in SEPTERNA INC, MONTE ROSA THERAPEUTICS INC (GLUE) and ITEOS THERAPEUTICS INC (ITOS). The fund showed a lot of confidence in some stocks as they added substantially to VERVE THERAPEUTICS INC (VERV), FORTE BIOSCIENCES INC (FBRX) and MOLECULAR PARTNERS AG.

BVF INC/IL Annual Return Estimates Vs S&P 500

Our best estimate is that BVF INC/IL made a return of -6.81% in the last quarter. In trailing 12 months, it's portfolio return was -0.19%.

New Buys

Ticker	$ Bought
septerna inc	56,151,400
monte rosa therapeutics inc	19,185,400
iteos therapeutics inc	17,856,000
rapt therapeutics inc	14,595,300
palvella therapeutics inc ne	8,358,660

New stocks bought by BVF INC/IL

Additions

Ticker	% Inc.
verve therapeutics inc	962
forte biosciences inc	398
molecular partners ag	205
xencor inc	169
cidara therapeutics inc	55.43
axsome therapeutics inc	32.7
verastem inc	24.64
revolution medicines inc	20.2

Additions to existing portfolio by BVF INC/IL

Reductions

Ticker	% Reduced
4d molecular therapeutics in	-63.83
third harmonic bio inc	-45.65
olema pharmaceuticals inc	-37.43
89bio inc	-36.38
kura oncology inc	-23.85
structure therapeutics inc	-20.88
ikena oncology inc	-15.99
tyra biosciences inc	-15.38

BVF INC/IL reduced stake in above stock

Sold off

Ticker	$ Sold
vistagen therapeutics inc	-6,020,000
newamsterdam pharma company	-25,264,300
ionis pharmaceuticals inc	-58,162,300
ideaya biosciences inc	-44,668,600
cg oncology inc	-37,526,100
molecular templates inc	-733,744
pieris pharmaceuticals inc	-4,312,660

BVF INC/IL got rid off the above stocks

Sector Distribution

BVF INC/IL has about 87.6% of it's holdings in Healthcare sector.

Sector	%
Healthcare	87.6
Others	12.4

Market Cap. Distribution

BVF INC/IL has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	57.1
SMALL-CAP	19.3
UNALLOCATED	12.4
MICRO-CAP	10.1

Stocks belong to which Index?

About 48.4% of the stocks held by BVF INC/IL either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	51.6
RUSSELL 2000	48.4

Top 5 Winners (%)		%
FBRX	forte biosciences inc	292.1 %
CDTX	cidara therapeutics inc	122.4 %
ALLK	allakos inc	85.2 %
TENX	tenax therapeutics inc	78.9 %
ELDN	eledon pharmaceuticals inc	65.5 %

Top 5 Winners ($)		$
MLTX	moonlake immunotherapeutics	76.3 M
CDTX	cidara therapeutics inc	16.2 M
ELDN	eledon pharmaceuticals inc	10.3 M
FBRX	forte biosciences inc	10.1 M
ALLK	allakos inc	9.2 M

Top 5 Losers (%)		%
EPIX	essa pharma inc	-70.5 %
RPTX	repare therapeutics inc	-61.9 %
VIGL	vigil neuroscience inc	-50.0 %
FHTX	foghorn therapeutics inc	-49.3 %
KURA	kura oncology inc	-46.6 %

Top 5 Losers ($)		$
TYRA	tyra biosciences inc	-43.4 M
OLMA	olema pharmaceuticals inc	-40.0 M
EPIX	essa pharma inc	-37.4 M
KYMR	kymera therapeutics inc	-36.6 M
KURA	kura oncology inc	-30.7 M

BVF INC/IL Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BVF INC/IL

BVF INC/IL has 53 stocks in it's portfolio. About 70.1% of the portfolio is in top 10 stocks. TYRA proved to be the most loss making stock for the portfolio. MLTX was the most profitable stock for BVF INC/IL last quarter.

Last Reported on: 14 Feb, 2025

	Ticker	Namesorted descending	% Portfolio	Shares Held	$ Value	Type	% Change
	MLTX	moonlake immunotherapeutics	36.25	19,751,300	1,069,530,000	reduced	-9.19
Historical Trend of MOONLAKE IMMUNOTHERAPEUTICS Position Held By BVF INC/IL What % of Portfolio is MLTX?: Number of MLTX shares held: Change in No. of Shares Held:
	KYMR	kymera therapeutics inc	7.04	5,161,800	207,659,000	unchanged	0.00

	RVMD	revolution medicines inc	6.20	4,181,180	182,885,000	added	20.2

	AXSM	axsome therapeutics inc	3.98	1,388,060	117,444,000	added	32.7

	MIRM	mirum pharmaceuticals inc	3.92	2,796,510	115,636,000	reduced	-9.08

	XOMA	xoma royalty corporation	3.24	3,633,740	95,494,800	unchanged	0.00

	PTGX	protagonist therapeutics inc	2.49	1,900,020	73,340,600	added	2.69

		gh research plc	2.47	10,400,200	72,801,100	unchanged	0.00

	CGEM	cullinan therapeutics inc	2.37	5,750,680	70,043,300	unchanged	0.00

	ZYME	zymeworks inc	2.14	4,308,940	63,082,800	reduced	-6.49

		septerna inc	1.90	2,452,020	56,151,400	new

	TYRA	tyra biosciences inc	1.86	3,944,190	54,824,300	reduced	-15.38

		ac immune sa	1.79	19,522,400	52,710,600	unchanged	0.00

	XNCR	xencor inc	1.78	2,288,760	52,595,700	added	169

		structure therapeutics inc	1.63	1,771,420	48,040,800	reduced	-20.88

	CELC	celcuity inc	1.54	3,466,000	45,369,900	unchanged	0.00

		galapagos nv	1.46	1,569,420	43,159,100	unchanged	0.00

	VERV	verve therapeutics inc	1.32	6,904,050	38,938,800	added	962

	ANNX	annexon inc	1.22	7,000,000	35,910,000	unchanged	0.00

	AGIO	agios pharmaceuticals inc	1.20	1,073,760	35,283,600	reduced	-9.78